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Abstract
Background: Metastatic progression of breast cancer involves phenotypic plasticity of the carcinoma cells moving
between epithelial and mesenchymal behaviors. During metastatic seeding and dormancy, even highly aggressive
carcinoma cells take on an E-cadherin-positive epithelial phenotype that is absent from the emergent, lethal metastatic
outgrowths. These phenotypes are linked to the metastatic microenvironment, though the specific cells and induction
signals are still to be deciphered. Recent evidence suggests that macrophages impact tumor progression, and may
alter the balance between cancer cell EMT and MErT in the metastatic microenvironment.
Methods: Here we explore the role of M1/M2 macrophages in epithelial-mesenchymal plasticity of breast cancer cells
by coculturing epithelial and mesenchymal cells lines with macrophages.
Results: We found that after polarizing the THP-1 human monocyte cell line, the M1 and M2-types were stable and
maintained when co-cultured with breast cancer cells. Surprisingly, M2 macrophages may conferred a growth advantage
to the epithelial MCF-7 cells, with these cells being driven to a partial mesenchymal phenotypic as indicated by spindle
morphology. Notably, E-cadherin protein expression is significantly decreased in MCF-7 cells co-cultured with M2
macrophages. M0 and M1 macrophages had no effect on the MCF-7 epithelial phenotype. However, the M1
macrophages impacted the highly aggressive mesenchymal-like MDA-MB-231 breast cancer cells to take on a
quiescent, epithelial phenotype with re-expression of E-cadherin. The M2 macrophages if anything exacerbated
the mesenchymal phenotype of the MDA-MB-231 cells.
Conclusion: Our findings demonstrate M2 macrophages might impart outgrowth and M1 macrophages may contribute
to dormancy behaviors in metastatic breast cancer cells. Thus EMT and MErT are regulated by selected macrophage
phenotype in the liver metastatic microenvironment. These results indicate macrophage could be a potential
therapeutic target for limiting death due to malignant metastases in breast cancer.
Keywords: Macrophage polarity, Mesenchymal to epithelial reverting transition, Epithelial to mesenchymal
transition, Metastatic microenvironment
* Correspondence: wellsa@upmc.edu
1Department of Pathology, University of Pittsburgh, and Pittsburgh VA Health
System, Pittsburgh, PA, USA
Full list of author information is available at the end of the article
© 2016 The Author(s). Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Yang et al. BMC Cancer  (2016) 16:419 
DOI 10.1186/s12885-016-2411-1
Background
Recurrences at metastatic sites represent a major cause of
mortality in breast cancer patients [1, 2]. It is reported that
20–45 % of breast cancer patients will relapse years or
even decades after the resection of the primary tumor [3].
Only a small number of the disseminated tumor cells that
lodge in secondary organs will eventually grow to form a
clinically evident metastasis; cancer cells can remain dor-
mant in secondary organs for years [4, 5]. The existence of
such dormant cancer cells at metastatic sites has been de-
scribed previously as quiescent solitary cells that neither
proliferate nor undergo apoptosis [1, 6]. Therefore, a com-
prehensive understanding of the “switch” from a dormant
to a growth state is crucial to elucidate the mechanism of
cancer progression and recurrence, might lead to the de-
velopment of novel treatments for cancer metastasis.
The cancer-associated Epithelial-to-Mesenchymal Tran-
sition (EMT) has been strongly correlated with metastasis
and shortened life expectancy of many carcinomas, has
been proposed as a mechanism for enabling cancer cell in-
vasion and dissemination [7, 8]. Nevertheless, EMT is re-
versible and that a reversion back towards the epithelial
phenotype may occur at the secondary metastatic site
(MErT) [9]. Current opinion and our previous studies re-
vealed that metastatic breast cancer dormancy is likely not
sustainable by the invasive, mesenchymal phenotype but
rather through a partial epithelial reversion in which
the cells are in a quiescent state [9, 10]. Accumulating
evidence suggests that MErT may be critical for breast
cancer ectopic survival and dormancy once a distant
metastasis is involved. Furthermore, studies have shown
that a secondary epithelial to mesenchymal transition is
thought to underlie latent metastatic outgrowth [10–12].
Therefore, EMT and MErT may determine dormant or
active states of the tumour, respectively, and allow for an
indeterminate number of metastases formation.
It is established that distant metastases involves dissemi-
nated tumor cells adapting to the foreign environment,
suggesting that the microenvironment is capable of regu-
lating a series of switches between EMT and MErT pheno-
types [13–15]. The triggers for the second mesenchymal
transition of these dormant cells are not known though
initial studies in an ex vivo microphysiological system sug-
gest that inflammatory signals may underlie this [16, 17].
In breast cancer stroma, key cells of the innate inflamma-
tory process, macrophages, can occupy more than 50 % of
the breast tumour mass and influence breast cancer prog-
nosis [18, 19]. Macrophages are heterogeneous in popula-
tion and can be classified within a spectrum of M1 or M2,
polarising to each dependent on the stimuli present at
time of activation. Recently, it has been shown that tumor-
associated macrophages (TAMs), which are characterized
by M2 macrophages, contribute to EMT and cancer me-
tastasis from primary tumor to a distant tissue [20, 21].
However, the roles of macrophages on modulating the bal-
ance between EMT and MErT of breast cancer cells in re-
sponse to a metastatic microenvironment remain unclear.
The goal of this study was to determine the functional
contributions of M1/M2 macrophages to epithelial-
mesenchymal plasticity in breast cancer cells, and to elu-
cidate the underlying effects of macrophage polarization
on tumor dormancy or growth state for emergency in
metastatic tumors. This work might highlight a novel
function of macrophage for colonization in the distant
metastatic site, and serve as a foundation to explore




Phorbol 12-myristate 13-acetate (PMA), Lipopolysac-
charides (LPS) and Hoechst 33258 dye were from
Sigma-Aldrich (St. Louis, MO, USA). The cytokines for
interferon γ (IFNγ), interleukin-4 (IL-4) and interleukin-13
(IL-13) were from R&D Systems (Minneapolis, MN, USA).
The antibody for CD163 was from Abcam (Cambridge,
MA, USA). The primary antibodies for E-cadherin, GAPDH
were from Cell Signaling Technology (Danvers, MA, USA).
Antibodies for fluorescein isothiocyanate (FITC)-conjugated
CD68, FITC-conjugated CD206, FITC-conjugated CD163,
FITC-conjugated HLA-DR and isotype control were from
BD Biosciences (San Jose, CA, USA). FITC-conjugated E-
cadherin antibody was from BioLegend (San Diego, CA,
USA). Hepatocyte maintenance medium (HMM) and
SingleQuots were from Lonza (Anaheim, CA, USA).
Cell culture and differentiation
The breast cancer cell lines MCF7, MDA-MB-231 and
the human THP-1 cell line were purchased from ATCC
(Manassas, VA, USA). MDA-MB-231 and MCF7 cell lines
were transfected with red fluorescent protein (RFP) as pre-
viously described [9]. To maintain selection for RFP posi-
tive breast cancer cells, MCF-7 cells were cultured with
900 μg/ml G418, and MDA-MB-231 were cultured with
5 μg/ml puromycin in RPMI-1640 (Life Technologies,
Carslbad, CA) supplemented with 10 % FBS until used in
the experiments. THP-1 cells were cultured in RPMI 1640
supplemented with 10 % FBS, 100 mg/ml penicillin, and
100 mg/ml streptomycin (Gibco, Life Technologies, Grand
Island, NY, USA).
THP-1 cells were differentiated and polarized according
to established protocols [20, 27], with minor modifica-
tions. Briefly, THP-1 cells were plated in RPMI media and
treated with 320 nM PMA for 72 h, cells that adopted an
adherent macrophage-like phenotype were selected as M0
macrophage. To generate M1-polarized macrophages,
THP-1 cells were treated with 320 nM PMA for 6 h and
then cultured with PMA plus 100 ng/ml LPS and 20 ng/
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ml IFNγ for the remaining 66 h of a total incubation time
of 72 h. To generate M2-polarized macrophages, THP-1
cells were treated with 320 nM PMA for 6 h, and then
cultured with PMA plus 20 ng/ml IL-4 and 20 ng/ml IL-
13 for another 66 h of a total incubation time of 72 h.
Peripheral blood mononuclear cells (PBMCs) were ob-
tained using a previously described method [22, 23].
Briefly, we mixed the human peripheral blood sample with
an equal volume of room temperature PBS, pelleted the
leukocyte/RBC fraction by centrifuging the cells 15 min at
200 × g, at room temperature. The supernatant was re-
moved and the leukocyte/RBC cell suspension brought to
a final volume of 40 ml with 1× PBS. The 10 ml leukocyte/
RBC/PBS mixture was layered over 3 ml Ficoll-Hypaque
(10771 SIGMA) solution and centrifuged 20 to 30 min
900 g, 18° to 20 °C, with no brake. The mononuclear
lymphocyte cell were washed by adding HBSS (∼3 times
the volume of the mononuclear cell layer) and centrifuging
10 min at 450 to 600 × g, 18° to 20 °C. Mononuclear cells
were resuspended in RPMI-1640 medium and seeded on
poly-L-Lysine coated coverslips. Media was changed after
4 h to remove un-attached cells. For polarization we added
50 ng/ml GM-CSF for M1 or 50 ng/ml M-CSF for M2,
and replenished after 48 h for total 96 h. Media was then
supplemented with LPS (100 ng/ml) and IFNγ (20 ng/ml)
for M1 or IL-4 (20 ng/ml) and IL-13 (20 ng/ml) for M2
for 72 h. We seeded 200,000 RFP-labeled MCF-7 or
MDA-MB-231 onto the macrophages monolayer in HMM
medium after thoroughly wash to remove cytokines. Cells
were fixed after 5 days.
Macrophage and breast cancer cell co-culture
One million THP-1 cells, or primary human monocyte-
derived macrophages, were plated in 6-well plates in 2-mL
RPMI1640 with 10 % FBS plus PMA and M1-trophic (IFN-
γ and LPS) or M2-trophic (IL-4 and IL-13) cytokines
treatment for 72 h to induce differentiation into M1/
M2 macrophages. M0 macrophages, cells treated with
only PMA were taken as controls. After a thorough wash
to remove PMA and cytokines, 2 × 105 per well MCF7 or
MDA-MB-231 cells were seeded onto the M1/M2, M0
macrophages monolayer and co-cultured in HMMmedium
for additional 5 days. Breast cancer cell lines were alone
planted in HMM medium as the control group.
In addition, the M0, M1 and M2- conditioned media
(CM) was collected everyday for breast cancer cells
treatment. The culture supernatants from macrophages
were collected 24 h later, by centrifuging at 500 × g for
5 min, as the macrophage CM. After 24 h, the normal
growth medium RPMI1640 was discarded, MCF-7 or
MDA-231 cells were treatment M0, M1 or M2 CM was
added totally for 5 days, and changed M0, M1 or M2
CM everyday.
Co-culture systems were established by using transwell
inserts (0.4 mm pore, polycarbonate membrane; Costar,
Cambridge, MA, USA) and transferred to six-well culture
plates. M0, M1 or M2 macrophages (1 × 106 cells) were
loaded in the upper inserts, and MCF7 or MDA-MB-231
cells (2 × 105 cells) were put into the lower compartment
of the culture well and serum-starved for at least 12 h be-
fore co-culture. Macrophages co-cultures with MCF-7 or
MDA-MB-231 cells were performed in serum free HMM
for 5 days. Total cellular protein was extracted from
MCF7 or MDA-MB-231 cells exposed to different experi-
mental conditions.
Flow cytometry
Phenotypic changes in macrophages were verified by flow
cytometry using the BD LSRFortessa flow cytometer (BD
Biosciences, Franklin Lakes, NJ). After blocking human
FcRs, cells were washed and resuspended in PBS supple-
mented with 1 % heat-inactivated FBS and 0.01 % NaN3.
For CD68 staining, cells were fixed and permeabilized
with a BD Cytofix/Cytoperm Fixation/Permeabilization
Solution Kit (BD Biosciences, Franklin Lakes, NJ). Cells
were then incubated with the FITC-CD68 antibody. For
surface markers, cells were incubated with FITC-coupled
antibodies to CD206, CD163, HLA-DR, as well as isotype
matched control antibodies, for 30 min at 4 °C in the dark.
Flow cytometry analyses of co-cultures were accomplished
by non-enzymatic dissociation of cells from the culture
plates. The cells were fixed in 2 % Paraformaldehyde for
30 min, permeabilized with 1 % Triton for 3 min, and in-
cubated with a FITC-conjugated E-cadherin antibody for
30 min. Following the final washing step, labeled cells
were analyzed by flow cytometry using BD FACSDiva
Software (BD Biosciences, Franklin Lakes, NJ). The mixed
macrophage-breast cancer cell suspension was gated as to
identify breast cancer cells using RFP fluorescence versus
side scatter. Gates were set on the RFP+ population, and
this gated population was analyzed for E-Cadherin expres-
sion. The RFP- population was analyzed for macrophage
marker expression.
Imaging
Phase contrast images of whole cell morphology were
captured by an Olympus inverted scope and digitally
analyzed using Spot Advanced software (Diagnostics In-
struments, Macomb, MI). Immunofluorescent staining of
co-cultures was conducted to evaluate E-cadherin expres-
sion. Cell slides were incubated with the primary antibody
for E-cadherin (1: 500) at 4 °C overnight and then with
Alexa Fluo® 488-conjugated secondary antibody at room
temperature for 1 h. Counterstains used were 0.1 %
Hoechst 33258 dye for nuclei. Immunofluorescent images
were captured on an Olympus Fluoview 1000 scope
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(Olympus, Center Valley, PA) and captured using Fluo-
view Viewer.
Images from co-cultures in HMM versus MCF-7 or
MDA-MB-231 in RPMI growth medium were imported
into ImageJ Version 1.44i (U. S. National Institutes of
Health, Bethesda, Maryland). Two fields per experimental
condition were analyzed. Cell perimeters and midpoint
widths were manually traced and measured in pixel units
using the ImageJ functions. The ratio of width versus per-
imeter was computed for each cell and the mean values,
standard deviations, and Student’s t test (2 tailed) were
calculated using Prism 5 (GraphPad Software, San Diego,
CA, USA).
Breast cancer cells viability was assessed as the quantity
of RFP+ cells to the total cell number of co-cultures. Man-
ual calculations of the RFP+ cells within 10 random fields
with approximately 500–1000 cells were performed.
Xenografts
Metastatic samples in mice: Prostate cancer (PCa) DU145
cells were obtained from ATCC, cultured in RPMI-1640
media supplemented with 10 % fetal bovine serum (FBS)
in the presence of 100 u/mL penicillin and 0.1 mg/mL
streptomycin. Seven-week-old male NOD/SCID gamma
mice were purchased from the Jackson Laboratories (Bar
Harbor, ME). For the in vivo hepatic metastasis model cells
were injected into the spleen and both liver and spleen ex-
amined. After anesthetizing the mice, a transverse incision
in the left flank was made to expose the spleen; a half a
million viable PCa DU145 cells were injected into the
spleen using a 27-gauge needle. Five weeks after inocula-
tion, the tumor xenograft tissues of NOD/SCID gamma
mice were fixed in 10 % neutral buffered formalin for
immunohistochemical staining. The Mouse on Mouse
Kit (Vector Labs, Berlingame, CA), was used for posi-
tive labeling by comparing serial sections incubated
with the primary antibodies for E-cadherin or CD163,
and the biotinylated secondary antibody alone. Labeling
was visualized with the Vectastain Elite kit (Vector
Labs). The AAALAC-accredited Institutional Animal
Care and Use Committees of the Veteran’s Administra-
tion Pittsburgh Health System approved all animal
studies and procedures.
Western blot
Cells were lysed in SDS buffer (20 mM Tris-HCl pH 7.4,
150 mM NaCl, 5 mM EDTA, 5 mM EGTA and 1 % SDS)
containing complete protease inhibitor cocktail (Roche).
Protein concentration was determined by the Bradford
protein assay and gels loaded with equal amounts of pro-
tein per lane. A 8 % SDS–PAGE gel resolved cell lysates
and were subsequently transferred to a PVDF membrane.
Membranes were blocked with 5 % serum albumin for 1 h
and incubated overnight with primary antibody E-cadherin
or GAPDH. The membranes were washed and incubated
with peroxidase-conjugated secondary antibodies for 1 h,
and then detected by enhanced chemiluminescence.
Statistical analysis
Data analysis involved use of GraphPad software (Graph-
Pad Prism version 5.00 for Windows, GraphPad Software,
San Diego, CA, USA). Results are expressed as mean ±
s.e.m. Differences were analyzed by t-test or ANOVA, and
results were considered significant at P <0.05.
Results
M1 or M2 phenotype is stable following co-culture with
breast cancer cells in hepatic microphysiologic system
Human THP-1 cells are a widely used model for differ-
entiated tissue macrophages that closely resembles na-
tive monocyte-derived macrophage differentiation [24].
To explore the interaction between macrophages and
breast cancer cells, we used M1- or M2-polarized THP-
1 macrophages in co-culture with breast cancer cells. As
the ultimate goal is to determine the macrophage role in
metastatic breast cancer cell dormancy we chose a liver
tissue medium that allows for breast cancer survival, but
is devoid of serum, HMM medium. The protocol for the
experiment is shown in Additional file 1: Figure S1,
THP-1 cells were treated with PMA for 72 h after which
fully differentiated macrophages were generated (as ‘M0’
in Fig. 1). At this stage, THP-1 cells were treated with
PMA for 6 h, followed by stimulation of either IFNγ/LPS
or IL-4/IL-13 for a resting period of 72 h to obtain M1-
and M2-like phenotypes, respectively (denoted as ‘M1’ and
‘M2’, Fig. 1). Morphology analysis showed that undifferen-
tiated THP-1 cells were loosely suspended round cells.
When treated with PMA, THP-1 cells quickly stopped
proliferating, became attached, differentiated into tightly
adherent (Fig.1a). Interestingly, M1/M2-polarized THP-1
macrophages displayed a fully differentiated amoeboid
morphology including oval, elongated, or pseudopodia-like
cells compared with the spherical shape of M0 macro-
phages (Fig.1a). These morphological changes of the mac-
rophages were similar to those described earlier [12].
Phenotypes were confirmed via flow cytometric analysis
of standardized cell surface markers. As shown in Fig.1b
and Additional file 2: Figure S2a, the expression of macro-
phage marker CD68 was markedly upregulated on PMA-
treated macrophages, indicating that THP-1 monocytes
were well differentiated to macrophages. M1 macrophage
marker (HLA-DR) was markedly increased with IFNγ/LPS
pre-treatment, while the expression of HLA-DR was very
low with IL-4/IL-13 pre-treatment. Moreover, results
showed that the level of M2 macrophage–specific marker
CD206 was upregulated in IL-4 plus IL-13 treatment,
whereas IFNγ/LPS did not affect CD206 expression (Fig.1b
and Additional file 2: Figure S2a).
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To further validate that this protocol was efficient in
eliciting M1 and M2-like polarization in the THP-1
cells that was stable for the experimental time course.
Following 5 days of co-culture with breast cancer cells in
HMM medium, we found that the M1 or M2 macrophage
markers in co-cultured cells. The mixed macrophage-
breast cancer cell suspension was gated as to exclude
breast cancer cells using RFP fluorescence versus side
scatter. Gates were set on the RFP- population, and this
gated population was analyzed for M1 or M2 macro-
phages. Flow cytometric analysis revealed the levels of M2
macrophage marker (CD206, CD163) and M1 macro-
phage marker (HLA-DR) were very low in MCF-7 cells
culture alone, suggested no expression of macrophage
marker in breast cancer cells (Fig.1c and Additional file 2:
Figure S2b). After 5 days of co-culture cells, we found that
the IL-4/IL-13 pre-treatment led to significantly increased
expression of M2 macrophage–specific markers CD206
and CD163, whereas IFNγ/LPS pre-treatment resulted in
upregulated level of M1 macrophage–specific marker
HLA-DR with no effect on the expression of upregulated
CD206 and CD163 (Fig.1c and Additional file 2: Figure
S2b). Together, these data indicated that pre-polarized M1
and M2 macrophages retained their phenotype even after
coculturing with MCF-7 cells.
M1 and M2 macrophages differentially affect breast
cancer cells outgrowth in HMM medium
To investigate the effects of M1 and M2 macrophages on
breast cancer cells numbers, we observed the outgrowth
Fig 1 Characterization of THP1-derived M1- or M2-like macrophages when co-cultured with breast cancer cells for 5 days. a THP-1 cells were
PMA-treated for 6 h, with addition of M1-polarizing or M2-polarizing cytokines during the final 66 h of treatment. Morphological changes in response
to M1-trophic or M2-trophic cytokines stimuli. (Bar = 50 μm). b Flow cytometry based analysis of M0, M1 and M2 macrophages for HLA-DR, CD206 or
CD68 expression. The grey background represents unstained control. c Flow cytometric analysis of the indicated markers on M0, M1 and M2
macrophage subsets by breast cancer cells co-culture. M0, M1 or M2 macrophages co-cultured with MCF-7 cells in serum-free hepatocyte
maintenance medium (HMM) for 5 days, mono-cultured MCF-7 in their normal growth medium (RPMI 1640 with 10 % serum). CD206 and
CD163 are both markers for M2 macrophages. HLA-DR is the marker for M1 macrophages. The blue line indicates mono-cultured MCF-7 cells,
the purple line indicates M0 macrophages co-cultured with MCF-7 cells, the green line indicates M1 macrophages co-cultured with MCF-7 cells,
the red line indicates M2 macrophages co-cultured with MCF-7 cells. Shown are represented of at least three independent experiments
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of RFP positive MCF-7 cells and RFP positive MDA-
MB-231 cells within the co-culture system in HMM
medium via imaging. The noninvasive breast cancer
line MCF-7 cells and highly invasive and metastatic
MDA-MB-231 cells exogenously expressing RFP were
seeded under three culture conditions: (1) co-cultured
with M0, M1 or M2 macrophages in serum-free HMM,
(2) mono-cultured RFP-MCF-7 or RFP-MDA-MB-231
in serum-free HMM as the negative control, and (3)
mono-cultured RFP-MCF-7 or RFP-MDA-MB-231MCF-7
in their normal growth medium (RPMI with 10 % serum)
as the positive control.
Measurement of RFP positive MCF-7 cells by micros-
copy revealed a slowly decreasing number of MCF-7 cells
in HMM medium was observed throughout the 5-day
experimental timeframe (negative control), while the
MCF-7 cells significantly increased in RPMI 1640 with
10 % serum (positive control) (Fig.2a). At day 3, MCF-7
cells co-cultured with M0 or M1 macrophages in serum-
free HMM medium maintain low survival and outgrowth
of MCF-7 cells compared with MCF-7 cells mono-cultured
in serum-free HMM, there was no statistically significant
difference in cell viability of MCF-7 cells among these
groups (P >0.05, ANOVA). Moreover, there was also no sig-
nificant difference in MCF-7 cells outgrowth in co-culture
with M0 or M1 macrophages (Fig. 2a). Notably, the MCF-7
cells substantially increased after 5 days of co-culture with
M2 macrophages in HMM as observed by microscopy
(Fig. 2a), indicating that the M2 macrophages contribute to
a growth advantage of MCF-7 cells.
Fig 2 Changes in cell viability of breast cancer cells following co-culture with M1 or M2 macrophages. a M2 macrophages may confer a growth
advantage to MCF-7 cells. A Phase contrast imaging with a fluorescence overlay (Red MCF-7 cells) are representative images on Day 1, Day 3 and
Day 5 across 5 conditions. (Bar = 100 μm). MCF-7 cells co-cultured with M0, M1 or M2 macrophages in serum-free hepatocyte maintenance
medium (HMM), MCF-7 cells mono-cultured in serum-free HMM as the negative control, mono-cultured MCF-7 in their normal growth medium
(RPMI 1640 with 10 % serum) as the positive control. **, P <0.01. b M1 macrophages may inhibit a growth advantage of MDA-MB-231 cells by
microscope on days 5. A Phase contrast imaging with a fluorescence overlay (Red MDA-MB-231 cells) are representative images on Day 1, Day 3
and Day 5 across 5 conditions. (Bar = 100 μm). *, P <0.05. **, P <0.01. For both (a) and (b), images are representative of three independent experiments
each in triplicate
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We also found a slow decrease in RFP positive MDA-
MB-231 cells in HMM medium for 5 days, but within the
normal growth medium, MDA-MB-231 cells experienced
exponential growth (Fig. 2b). Interestingly, the MDA-MB-
231 cell number was substantially reduced after 5 days of
co-culture with M1 macrophages in comparison with M2
or M0 co-culture (Fig. 2b). These results demonstrated
M2 macrophages may confer a growth advantage to breast
cancer cells.
M2 macrophages promote a mesenchymal phenotype
in MCF-7 cells
To explore the effect of macrophages on breast cancer cell
phenotype, we co-cultured the epithelial MCF-7 cells with
M0, M1 or M2 macrophages in HMM medium and ob-
served RFP-MCF-7 cells morphology after 5 days of co-
culture. As shown in Fig. 3a, MCF-7 cells exhibited their
usual cobblestone appearance and tight cell-cell contacts
in standard growth medium (1640 + 10%FBS). Import-
antly, in MCF-7 and M2 macrophages co-cultures, a sub-
population of the MCF-7 cells transformed into more
elongated, spindle-shaped cells, that did not readily form
cell-cell contacts (Fig. 3a). For accurate evaluation of epi-
thelial and mesenchymal morphologic phenotypes, we
measuried the ratio of midpoint diameter to cell perimeter
as described [12] using Image J software. Epithelial-shaped
cells were cobblestone similar to cuboidal shape with a
rounded aspect; the mesenchymal-shaped cells were elon-
gated, spindle shape with low ratio of midpoint diameter
to cell perimeter. This parameter reflects the morpho-
logical changes from epithelial cells to mesenchymal cells
as occurs during EMT. MCF-7 cells polarity, ratio of
Fig. 3 M2 macrophages confer a partial mesenchymal phenotypic shift of MCF-7. a Fluorescent imaging depicts RFP-MCF-7 cells co-cultured with
M0, M1 or M2 macrophages in serum-free hepatocyte maintenance medium (HMM) for 5 days. MCF-7 cells mono-cultured in serum-free HMM
on day 5 as the negative control, mono-cultured MCF-7 in their normal growth medium (RPMI 1640 with 10 % serum) on day 5 as the positive
control. (Bar = 10 μm). Arrows indicate more elongated, spindle-shaped and mesenchymal-like cells. MCF-7 mesenchymal phenotypic shift in a
quantified by the ratio of the midpoint diameter divided by cell perimeter. Data are mean ± s.e.m of 3 independent experiments. **, P <0.01. NS
indicates not significant. b MCF7 cells co-cultured with M2 macrophages decreased E-cadherin expression. Immunofluorescence analysis of E-cadherin
expression in RFP-MCF7 cells by co-culture with M0, M1 or M2 macrophages. E-cadherin (green), RFP (red), DAPI (blue), Merge (yellow) (Bar = 10 μm).
Quantification of the percentage of E-cadherin negative cells in RFP-MCF-7 cells co-cultured with M0, M1 or M2 macrophages. **, P <0.01. 100 cells per
field in 10 different fields of each group were quantified. Data are represented of at least three independent experiments. c Flow analysis of E-cadherin
expression of RFP-MCF-7 population after 5 days of co-culture with M0, M1 or M2 macrophages. The grey background represents unstained control.
The black line indicates co-culture with M0 macrophages. The red line indicates co-culture with M1 macrophages. The blue line indicates co-culture with
M2 macrophages. Shown is one of two similar experiments
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midpoint diameter to cell perimeter, was significantly de-
creased by co-culture with M2 macrophages compared to
that by co-culture with M1 or M0 macrophages (Fig.3a).
To assess the relationship between macrophages and
breast cancer EMT, we detected the epithelial marker E-
cadherin expression given that the loss of E-cadherin is a
fundamental event in EMT. Immunofluorescence staining
showed E-cadherin was substantially expressed in MCF-7
cells membrane that forms cell–cell adherins junctions in
the RPMI controls (Fig.3b). E-cadherin expression was
retained at the membrane of MCF-7 cells co-cultured with
M0 or M1 macrophages in HMM medium (Fig.3b). How-
ever, E-cadherin protein expression was significantly de-
creased in MCF-7 cells co-cultured with M2 macrophages,
and MCF-7 cells failed to maintain membrane E-cadherin
expression (Fig.3b). In addition, there was no positive sig-
nal of E-cadherin expression for PMA-treated THP-1 cells.
Flow cytometric analyses of MCF-7 cells after 5 days of
co-culture with M2 macrophages displayed decreased E-
cadherin expression in comparison to M1 or M0 macro-
phages co-culture (Fig.3c). To corroborate the findings
in the primary cells, human monocyte-derived macro-
phages (MDMs) were utilized and E-cadherin staining
was performed as mentioned above. Similar observation
of E-cadherin expression was found in MDMs also
(Additional file 3: Figure S3a). These data indicate that
M2 macrophages could trigger EMT of MCF-7 cells in
the liver metastatic microenvironment.
The in vivo relevance of this finding has been initially
probed by examining the correlation between tumor cell
phenotype and infiltrating macrophage polarization. We
utilized a mouse model of prostate cancer DU145 cells in-
oculation into the spleen of NOD/SCID gamma mice with
spontaneous dissemination to the liver. This model pre-
sents both E-cadherin-positive and –negative nodules as
the tumor undergoes microenvironmentally-induced epi-
thelial – mesenchymal plasticity. Immunohistochemical
staining demonstrated that CD163, a marker of M2 mac-
rophages, was rarely detected in the area where E-cadherin
was prominently expressed but was markedly increased in
hepatic metastatic tumors with low E-cadherin levels
(Additional file 4: Figure S4). These initial, correlative data
indicate that M2 macrophages infiltration significantly cor-
relates with EMT in metastatic tumors.
M1 macrophages drive a mesenchymal to epithelial
transition, while M2 macrophages confer a more
mesenchymal phenotypic shift in MDA-MB-231 cells
Our previous study reported that hepatocytes drive MErT,
characterized by the re-expression of E-cadherin in MDA-
MB-231 cells [25]. To evaluate whether macrophages
could induce MErT in breast cancer cells at the metastatic
microenvironment, we co-cultured the mesenchymal-like
MDA-MB-231 cells with M0, M1 or M2 macrophages in
HMM medium and observed RFP-MDA-MB-231 cells
morphology after 5 days of co-culture. As shown in Fig. 4a,
MDA-MB-231 cells in standard growth medium (1640 +
10 % FBS) are characterized by a flattened, asymmetric
morphology and do not form cell-cell contacts. Import-
antly, in MDA-MB-231 and M1 macrophages co-cultures
in HMM medium, a sub-population of the MDA-MB-231
cells presented an epithelial shift as indicated by cobble-
stone morphology (Fig.4a). Interestingly, MDA-MB-231
cells became more elongated and spindle-shaped, and thus
more mesenchymal after coculturing with M2 macro-
phages (Fig.4a). The analysis of cell polarity revealed that
the ratio of midpoint diameter to cell perimeter in MDA-
MB-231 cells was the highest by co-culture with M1 mac-
rophages among co-culture cells or culture alone in normal
growth medium, whereas which was significantly downreg-
ulated coculturing with M2 macrophages (Fig.4a).
To further confirm whether macrophages could induce
an epithelial reversion as indicated by re-expression of
E-cadherin, we assessed E-cadherin expression in the
mesenchymal-like MDA-MB-231 cells after 5 days of
co-culture in HMM medium by immunofluorescence.
As shown in Fig.4b, E-cadherin was not expressed in
MDA-MB-231 membrane in the RPMI controls. In
addition, there was no positive signal of E-cadherin ex-
pression in MDA-MB-231 cells co-culture with M0 or M2
macrophages (Fig.4b). Notably, after 5 days of co-culture
with M1 macrophages in HMM medium, E-cadherin was
re-expressed in the sub-population of MDA-MB-231 cells
that altered their cell shape (Fig.4b). Five (5) days of co-
culture of MDA-231 cells with M1 macrophages increased
expression of E-cadherin whereas this was not seen in M2
or M0 macrophage co-cultures as assessed by flow cytom-
teric analyses (Fig.4c). As with primary monocyte-derived
macrophages, M1-polarized cells upregulated E-cadherin
expression in MDA-MB-231 cells, while M0- or M2-
polarized cells did not have any significant effect on E-
cadherin expression (Additional file 3: Figure S3b).
To examine whether macrophages determine the bal-
ance between EMT and MErT in breast cancer cells via
soluble factors, we used M1 and M2- conditioned media
(CM) to see if they can affect E-cadherin expression in
MDA-MB-231 or MCF7 cells. Western blot showed E-
cadherin being highly expressed in MCF-7 cells, but
there is no difference in E-cadherin expression with
M0, M1 or M2 CM treatment compared to control
groups (Additional file 5: Figure S5a). Similarly, M1 or
M2 CM did not change the expression of E-cadherin in
MDA-MB-231 cells compared with that in other groups
(Additional file 5: Figure S5). Furthermore, co-cultures
of M0, M1 or M2 macrophages and breast cancer cells
in the transwell system showed the expression of E-
cadherin did not differ in MCF7 or MDA-MB-231 cells
(Additional file 5: Figure S5b). The findings suggest
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either that direct contact co-culture of breast cancer
cells with macrophages is required to regulate epithelial-
mesenchymal plasticity in the liver metastatic microenvir-
onment or that the subset of cells that alter their
phenotype is insufficiently large to affect this whole
population assay. This latter possibility is unlikely given
the relatively high percentage of MDA-MB-231 cells
showing E-cadherin positivity with M1 co-culture or
the fraction of MCF-7 cells demonstrating loss of E-
cadherin in M2 co-culture.
Discussion
In this study, we established in vitro models based on co-
culture of breast cancer cells with macrophages in a liver
microenvironment medium so as to investigate possible
roles in regulating breast cancer metastasis dormancy and
outgrowth. Using THP-1 cells (a human monocytic cell
line) and a protocol we devised for their differentiation
and polarization into M1- and M2-like populations, we
found that dormancy and emergence from dormancy may
hinge upon the M1 or M2 type of the macrophage
polarization in the liver metastatic microenvironment,
thus making the metastatic niche a potential therapeutic
target to combat breast cancer metastasis.
The formation of micrometastases and the processes by
which micrometastases progress to macrometastases are
the main rate-limiting steps in clinically evident metasta-
ses [26]. Our foundational model posits that EMT and its
accompanying reduction in E-cadherin expression enables
carcinoma cells to disseminate from the primary tumor,
while MErT with upregulation of E-cadherin expression
allows disseminated carcinoma cells to integrate and
survive within ectopic metastatic microenvironments
[9, 12, 25, 27]. Outgrowth of these silent micrometas-
tases is accompanied by a second EMT with subse-
quent formation of secondary macroscopic metastases
Fig. 4 M1 macrophages accelerate mesenchymal to epithelial transition in MDA-MB-231. a Fluorescent imaging depicts MDA-MB-231 cells co-cultured
with M0, M1 or M2 macrophages in serum-free hepatocyte maintenance medium (HMM) for 5 days. MDA-MB-231 cells mono-cultured in serum-free
HMM on day 5 as the negative control, mono-cultured MDA-MB-231 in their normal growth medium (RPMI 1640 with 10 % serum) on day 5 as the
positive control. (Bar = 10 μm). MDA-MB-231 phenotypic shift in a quantified by the ratio of the midpoint diameter divided by cell perimeter. Data are
mean ± s.e.m of 3 independent experiments. *, P <0.05. **, P <0.01. b M1 macrophages drive the re-expression of E-cadherin in MDA-MB-231 breast
cancer cells. Immunofluorescence analysis of E-cadherin expression in RFP-MDA-MB-231 cells by co-culture with M0, M1 or M2 macrophages.
E-cadherin(green), RFP (red), DAPI (blue), Merge(yellow). (Bar = 10 μm). c Flow analysis of E-cadherin expression of RFP-MDA-MB-231 population
after 5 days of co-culture with M0, M1 or M2 macrophages. The grey background represents unstained control. The black line indicates co-culture with
M0 macrophages. The red line indicates co-culture with M1 macrophages. The blue line indicates co-culture with M2 macrophages. Shown is one of
two similar experiments
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[11, 28]. In addition to their role in constructing connec-
tions, the formation of cell heterotypic E-cadherin adhe-
sions in the metastatic target organ, MErT may result in
dormancy and enable the tumor cells to survive at a lower
metabolic load at the micrometastasis stage [29, 30]. Thus
the control of the epithelial-mesenchymal plasticity in
breast cancer cells in secondary organs remains key to this
mortal development. Therefore, we focused on the mech-
anism by which breast cancer cells regulate EMT/MErT
balance in liver microenvironment.
Diverse interactions between the host microenvironment
and cancer cells determine the course of tumor progression
and metastasis. Macrophages are a major component of the
breast cancer microenvironment. The human THP-1 cell
line is a widely used monocyte/macrophage model, and
the biologic behavior of THP-1 cells resembles monocyte-
derived macrophages with respect to adherence, phago-
cytic capacity, and surface marker and cytokine expression
[31, 32]. Therefore, we used the THP-1 monocyte cell line
as a model for macrophage differentiation and polarization,
and one with which to assess the effects of macrophages on
epithelial-mesenchymal plasticity in breast cancer cells. The
phenotypic state of the tumor cells is key to the fate of
the micrometastases and also the chemosensitivity
thereof [9, 25, 33].
Experimental and clinical data support the notion that
the survivors persisting in metastatic sites can exist in at
least three alternative states: (i) as solitary viable cancer
cells in a quiescent, nonproliferative state (dormancy); (ii)
as micrometastases, which remain as small, at least quasi-
quiescent lesions; or (iii) as actively growing macrometa-
static lesions [34]. Thus, the critical question as to whether
the micrometastatic cells are in a state of quiescence or
outgrowth is the key to dealing with tumor dormancy, and
should be at the forefront of new approaches to tumor
management. We previously reported that perturbations
of the parenchymal hepatocytes and NPCs in the liver
metastatic microenvironment may differentially contribute
to metastatic dormancy, stability, or emergence [12].
In examining NPC subsets, tissue macrophages, includ-
ing Kupffer cells, stand out. Macrophages represent one of
the main stromal cell populations, but are diverse as they
take on various functional phenotypes, referred to as M1
and M2 phenotypes. The role of macrophages in tumor
progression has been shown to be double-edged. Pro-
inflammatory, or classically activated M1 macrophages,
exert resistance against tumors and elicit tissue disruptive
reactions, while anti-inflammatory, or alternatively acti-
vated M2 macrophages, appear to have important roles in
promoting tumor growth and metastasis [35–39]. But
these earlier works all looked at the primary cancer situ-
ation. The actions in the metastatic site may be different if
not diametric. Our study demonstrates that the epithelial,
non-metastatic human immortalized breast cancer cell
line MCF-7 is exacerbated by M2 macrophage co-culture,
whereas the highly invasive and mesenchymal MDA-MB-
231 cell outgrowth is attenuated by M1 macrophage co-
culture. This provided evidence that the M2 macrophages
provided a favorable outgrowth environment, but M1
macrophages served as surrogate dormant for the breast
cancer cells in this culture system.
The metastatic microenvironment is composed of a
complex milieu of external cues arising from the tumor,
stroma, and parenchymal cells. It has been reported that
stromal cells regulate proliferation and motility of cancer
cells through both soluble factors and direct cell-cell inter-
actions [40]. In the present study, it was suggested that
cell-cell contact was required for macrophage phenotypic
subtypes to regulate epithelial-mesenchymal plasticity in
breast cancer cells. Recent reports have shown that direct
cell-cell contact between M2 macrophages and cancer
cells induced migration and invasion of cancer cells while
M1 macrophages reduced cancer cell invasion [41]. How-
ever, the numerous cell surface and extracellular matrix
(ECM) molecules potentially involved in cell-cell inter-
action are not identified yet, nor have the molecular
mechanisms by which these changes actively induce or re-
press gene expression in malignant cells. In fact, two-
dimensional (2D) culture did not recapitulate many of the
complex properties of the three-dimensional (3D) in vivo
microenvironment. One main issue is the stiffness of the
supporting substratum. Pathological, and in tissue culture
supra-physiological stiffness is well known to lead to a
mesenchymal transition of even non-neoplastic breast epi-
thelial cells [42, 43]. Our model system for the hepatic
niche moves beyond organotypic modeling into microphy-
siologic systems, providing the mechanical stresses and
oxygenation that is so important to the liver [17, 44]. As a
part of our research we are continuing to explore the be-
haviors of cancer cells in the metastatic microenvironment
to lie dormant or aggressively grow out through connec-
tion of this microphysiologic system with immune system
activation.
There are several possible outcomes after cancer cells
extravasate into a metastatic target tissue: apoptosis,
dormancy, or sustained proliferation [45]. Epithelial-
mesenchymal plasticity shifts may influence the discontinu-
ous behavior of cancers, in which some cancers remain
dormant for years after therapy, or to relapse and wreak
havoc [46]. The formation of cell heterotypic E-cadherin
adhesions in the metastatic target organ may result in
dormancy at the micrometastasis stage. After this quies-
cence, a secondary insult, independent of carcinoma per se,
to the local environment may induces renewed carcinoma
cell proliferation and escape from E-cadherin-mediated
contact inhibition during the metastatic seeding of dis-
seminated carcinomas [29]. In this study, we report that
macrophage phenotypic subtypes diametrically regulate
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epithelial-mesenchymal plasticity of breast cancer cells.
Hence, epithelial-mesenchymal plasticity may be appro-
priate as a metastasis outgrowth prevention strategies
in early stage carcinomas. Inducing the MErT program
in dormant micrometastases by M1 macrophages would
be a novel approach to maintain the long latency of a dor-
mant stage, and prevent occurrence of late disease recur-
rence. Furthermore, since an increasing number of studies
suggest a role of EMT in promoting chemoresistance [47],
combining chemotherapies with M2 macrophages dele-
tion holds promise to overcome chemoresistance in dor-
mant tumor cells, thus providing a unique therapeutic
approach to eradicate dormant tumor cells. In the near
future, improving our understanding of the molecular
regulation of the dynamic EMT/MErT programs during
tumor metastasis will help to uncover new signaling path-
ways that can be therapeutically manipulated to either
eliminate dormant tumor cells or to indefinitely maintain
them in this dormant state, thus preventing a progressive
metastatic disease.
Conclusion
The current findings represent the first study to test the hy-
pothesis and provide evidence that epithelial-mesenchymal
plasticity in the metastatic cascade is regulated by selected
M2 or M1 macrophages individually, which can serve as an
efficient tool to explore the molecular mechanisms regulat-
ing metastatic tumor cell dormancy and the transition to
metastatic growth. Our current study is limited by not fully
examining the macrophage phenotypes in the complex
micrometastatic niche; to achieve our ultimate goal of un-
derstanding cancer dormancy and progression in metastatic
sites, we need to develop robust bioreactor models that
incorporate appropriate tumor-host interactions. Still, this
better understanding of the molecular regulation of the
dynamic EMT/MErT programs during tumor metastasis
will help to provide much-needed effective treatment to re-
ducing the risk of recurrence.
Additional files
Additional file 1: Figure S1. Schematic of experimental protocol to
explore the role of macrophages on breast cancer cells outgrowth and
epithelial-mesenchymal plasticity. Day 0, THP-1 cells were seeded in their
normal growth medium (RPMI 1640 with 10 % serum). Day 3, Polarization
of the monocytic THP-1 cell line into M1- or M2-like macrophages.
Macrophages were co-cultured with RFP+ breast cancer cells (MCF-7 or
MDA-MB-231), the medium was changed to serum-free maintenance
HMM medium. Medium was changed every two days and breast cancer
cells viability assayed routinely. Day 8, Identification of macrophage
polarization and E-cadherin expression were examined by flow analysis or
immunofluorescence staining. (JPG 526 kb)
Additional file 2: Figure S2. Median fluorescence intensity (MFI) after
staining with M1 or M2 macrophage markers and analysis by flow
cytometry. The MFI served as a quantitative index of biomarker surface
expression. a Quantitation of the MFI for CD68, HLA-DR, CD206 expression in
M0, M1 and M2 macrophages. Data are mean ± s.e.m of three independent
experiments. **, P <0.01. NS indicates not significant. b Quantitation of the MFI
for CD206, CD163, HLA-DR expression in M0, M1 or M2 macrophages
co-cultured with MCF-7 cells in serum-free hepatocyte maintenance
medium (HMM) for 5 days, mono-cultured MCF-7 in their normal
growth medium (RPMI 1640 with 10 % serum). Data are mean ± s.e.m
of three independent experiments. **, P <0.01. (JPG 228 kb)
Additional file 3: Figure S3. E-cadherin expression of breast cancer cell
co-cultured with primary macrophage cell types. a Immunofluorescence
analysis of E-cadherin expression in RFP-MCF7 cells after co-culture with
M0, M1 and M2 programmed human monocyte derived macrophages
(MDMs) in serum-free hepatocyte maintenance medium (HMM) for 5 days.
E-cadherin (green), RFP (red), DAPI (blue), Merge (yellow) (Bar = 50 μm).
b Immunofluorescence analysis of E-cadherin expression in RFP-MDA-MB-
231 cells by co-culture with M0, M1 and M2 programmed human monocyte
derived macrophages (MDMs) in serum-free hepatocyte maintenance
medium (HMM) for 5 days. E-cadherin (green), RFP (red), DAPI (blue), Merge
(yellow) (Bar = 50 μm). Shown are one of two similar experiments.
(JPG 588 kb)
Additional file 4: Figure S4. Immunohistochemical analysis of E-
cadherin expression or M2 macrophage marker CD163 expression in
metastatic hepatic foci of mouse model of prostate cancer dissemination.
Metastatic foci in the liver were obtained from NOD/SCID gamma mice at
5 weeks after intrasplenic inoculation of prostate cancer (PCa) DU145 cells. The
livers were fixed in 10 % neutral buffered formalin for immunohistochemical
staining. Arrows indicate CD163 positive cells. (×200 magnification and scale
bar = 50 μm). Shown are representative nodules of greater than five each.
(JPG 1641 kb)
Additional file 5: Figure S5. Direct contact co-culture of breast cancer
cells with macrophages is required to regulate epithelial-mesenchymal
plasticity. a MCF-7 or MDA-231 cells were co-cultured with M0, M1 or M2
conditioned media (CM) for 5 days. b MCF-7 or MDA-231 cells were co-
cultured with M0, M1 or M2 macrophages in a transwell system for 5 days.
MCF-7 or MDA-231 cells were also cultured in their normal growth
medium (RPMI 1640 with 10 % serum) or in serum-free HMM. Western
blot analysis of E-cadherin protein expression in MCF-7 or MDA-231 cells.
GAPDH was used as a loading control. (JPG 390 kb)
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